News from the BioRegion STERN

Immatics, a leading company in the field of cancer immunotherapy, today announced that it has initiated enrollment of patients into a phase I trial of IMA203, its third T...

Unfortunately, the history of our company is coming to an end. The shareholders of Retina Implant AG resolved to dissolve the company at an extraordinary general meeting held on 19 March 2019.

Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that it will introd...

Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that it has entered...

Tübingen, Germany, February 20th, 2019 – Mireca Medicines GmbH, an ophthalmology start-up company developing treatments for inherited retinal degeneration, receives the validating “Notice of Allowance” from the USPTO for its proprietary formulation a...

Scientists at the University of Tübingen discover new mechanism that supports our immune system during sleep

Drug development veteran to focus on advancing the company’s preclinical portfolio of programs in naturally optimized mRNA

Chemists and microbiologists at Tübingen University discover sugar molecule that inhibits the growth of plants and microorganisms and is harmless to human cells ‒ An alternative to controversial glyphosate?

University of Tübingen researchers take RNA editing a step closer to treating hereditary diseases

Drug development veteran to lead CureVac’s global product development efforts as the company looks to advance its pipeline of mRNA-based products

"Future is our product" is the motto of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA. The institute produces innovations and solutions for industrial applications and bridges the gap between science and practice. This is ...

Senate and University Board confirm incumbent

Breakthrough in the investigation of feared pathogens − Previously unknown protein in a key role

Winfried Kretschmann, Minister-President of Baden-Württemberg and graduate of the University of Hohenheim congratulates his alma mater / Fritz Kuhn, Lord Mayor of Stuttga...

The growing numbers of resistant bacterial pathogenic agents and with this the increasing limitation of available active antibiotics poses one of the greatest challenges of the global health system. The research group “antibioPPAP”, funded for three years by the Ministry for Science and Culture from the State of Baden-Württemberg under the leadersh...